Our Services

The Cancer Center also manages ongoing clinical trials in oncology. All inquiries regarding the clinical trials can be coursed through the Cancer Center. 
 
List of Ongoing Clinical Trials
 
A Randomized, Open- Label, Phase III Study of Overall Survival Comparing Pembrolizumab (MK-3475) versus Platinum-based Chemotherapy in Treatment- Naïve Subjects with PD-L1 -positive advanced or metastatic Non- small cell lung Cancer (Keynote 042)
Type: Lung Cancer
Status: Ongoing
Investigators: Regina Edusma-Dy, MD and Joseph Parra, MD

A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First- Line Treatment of Recurrent/ Metastatic Head & Neck Squamous Cell Carcinoma
Type: Head & Neck Cancer Stage IV, Excluding Nasopharyngeal and Thyroid Cancer
Status: Ongoing
Investigators: Maria Belen E. Tamayo, MD and Joseph Parra, MD
 
A Phase III, Open- label, Multicentre, Randomized Trial to establish Safety and Efficacy of an EGF Cancer Vaccine in Inoperable, stage IV Biomarker- positive, wild- type EGF-R NSCLC Patients eligible to receive Standard Treatment and Supportive Care
Type: Lung Cancer
Status: Ongoing
Investigators: Maria Belen E. Tamayo, MD and Regina Edusma-Dy, MD

A Single- Arm, Open-Label, Phase II Study Evaluating the Efficacy Safety and Pharmocokinetics of HM61713 in Patients with T790M -positive Non-Small Cell Lung Cancer (NSCLC) after Treatment with an Epidermal Growth Factor Receptor - Tyrosine Kinase Inhibitor (EGFR- TKI)
Type: Lung Cancer
Status: Ongoing
Investigators: Barbara Marquez- Domingo, MD and Joseph Parra, MD

Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Long-Term Safety Efficacy Of Darbepoetin Alfa Administered At 500ug Once Every Three (3) Weeks In Anemic Subjects With Advanced Stage Non-Small Cell Lung Cancer, Receiving Multi-Cycle Chemotherapy 
Type: Lung Cancer
Status: Ongoing
Investigators: Maria Belen E. Tamayo, MD and Joseph Parra, MD

Phase 1 Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Reximmune-C2 (Hsv-Thymidine Kinase-M2 and Hgm-Csf Genes) In Refractory Patients with Primary Hepatocellular Carcinoma or Tumors Metastatic to the Liver
Type: Hepatocellular Cancer and Metastatic Liver Cancer
Status: Ongoing
Investigators: Maria Belen E. Tamayo, MD and Regina Edusma-Dy, MD
‚Äč
A Phase 3, Double-Blind, Randomized, Parallel-Group, Active Controlled Study to Compare the Efficacy and Safety of Ct-P6 and Perception as Neo-Adjuvant Treatment in Patient with Her2 Positive Early Breast Cancer
Type: Early Stage Breast Cancer
Status: Ongoing
Investigators: Maria Belen E. Tamayo, MD and Joseph Parra, MD